Your browser doesn't support javascript.
loading
Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
Regnery, Sebastian; Adeberg, Sebastian; Dreher, Constantin; Oberhollenzer, Johanna; Meissner, Jan-Eric; Goerke, Steffen; Windschuh, Johannes; Deike-Hofmann, Katerina; Bickelhaupt, Sebastian; Zaiss, Moritz; Radbruch, Alexander; Bendszus, Martin; Wick, Wolfgang; Unterberg, Andreas; Rieken, Stefan; Debus, Jürgen; Bachert, Peter; Ladd, Mark; Schlemmer, Heinz-Peter; Paech, Daniel.
Afiliação
  • Regnery S; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Adeberg S; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.
  • Dreher C; German Cancer Research Center (DKFZ), HIRO (Heidelberg Institute for Radiation Oncology), Heidelberg, Germany.
  • Oberhollenzer J; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.
  • Meissner JE; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.
  • Goerke S; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Heidelberg, Germany.
  • Windschuh J; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Heidelberg, Germany.
  • Deike-Hofmann K; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Heidelberg, Germany.
  • Bickelhaupt S; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.
  • Zaiss M; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.
  • Radbruch A; Max-Planck-Institute, Tübingen, Germany.
  • Bendszus M; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.
  • Wick W; Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Unterberg A; Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
  • Rieken S; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Debus J; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Bachert P; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Ladd M; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Heidelberg, Germany.
  • Schlemmer HP; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Heidelberg, Germany.
  • Paech D; Faculty of Physics and Astronomy, University of Heidelberg, Heidelberg, Germany.
Oncotarget ; 9(47): 28772-28783, 2018 Jun 19.
Article em En | MEDLINE | ID: mdl-29983895
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha